Glycemic Effects Of Sglt-2 Inhibitor Canagliflozin In Type 1 Diabetes Patients Using The Dexcom G4 Platinum Cgm

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25.7K citations

Pharmacy, Nephrology, Physiology +12

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine · 1993 · 24.7K citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

Medicine, Endocrinology, Physiology +11

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

Jane L. Chiang, M. Sue Kirkman, Lori M. Laffel et al. · Diabetes Care · 2014 · 969 citations · Full text

Medicine, Endocrinology, Immunology +15

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

Anne L. Peters, Elizabeth Buschur, John B. Buse et al. · Diabetes Care · 2015 · 830 citations · Full text

Medicine, Endocrinology, Pharmacology +17